Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Argus Health
Moodys
Mallinckrodt
Daiichi Sankyo
Boehringer Ingelheim
UBS
AstraZeneca
Federal Trade Commission

Generated: November 13, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Apotex Inc

« Back to Dashboard

Apotex Inc Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Apotex Inc pregabalin 203022 75MG CAPSULE;ORAL
Apotex Inc pregabalin 203022 200MG CAPSULE;ORAL
Apotex Inc sitagliptin; metformin hydrochloride 202426 50MG; 500MG TABLET; ORAL
Apotex Inc eletriptan hydrobromide 201536 40MG TABLET; ORAL
Apotex Inc memantine hydrochloride 090244 5MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Federal Trade Commission
Mallinckrodt
McKesson
Citi
Chubb
Healthtrust
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.